MedTrace Logo

The Prospective Evaluation of Pancreatic Function in Pancreas Transplant Recipients

NCT00571818 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2023-10-10

No results posted yet for this study

Summary

The purpose of this study is to understand how the pancreas functions after transplantation and particularly why high blood sugar levels develop. It will also analyze the effect of the medicines used to prevent rejection on blood sugar levels.

The hypothesis to be tested is that hyperglycemia more than six months after successful pancreas transplant results from a defect in insulin secretion, insulin resistance, or both.

Conditions

Interventions

PROCEDURE

Oral glucose tolerance test

test done over 2 hours

PROCEDURE

IV Glucose Tolerance Test

Done over 4 hours

Sponsors & Collaborators

  • University of Nebraska

    lead OTHER

Principal Investigators

  • James T Lane, MD · University of Nebraska

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-11-01
Primary Completion
2008-03-01
Completion
2010-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00571818 on ClinicalTrials.gov